Practical considerations for clinicians for transitioning patients on maintenance therapy with olaparib capsules to the tablet formulation of olaparib
AbstractPurposeOlaparib was originally formulated as 50  mg capsules with a recommended dose of 400 mg twice daily which requires patients to take 16 capsules a day. More recently, a tablet formulation with equivalent efficacy has become available and reduces the pill burden for patients to two tablets twice daily which is more convenient for patients. However, it is important to understand the key differences between the olaparib capsule and tablet formulations as they are not bioequivalent, and the doses are not interchangeable. Educating patients when transitioning from capsules to tablets is critical to avoid...
Source: Asia-Pacific Journal of Clinical Oncology - November 26, 2018 Category: Cancer & Oncology Authors: Michael Friedlander, Catherine Shannon, Jeffrey Goh, Clare Scott, Linda Mileshkin Tags: GUIDELINES/CONSENSUS Source Type: research

Receipt of radiotherapy after mastectomy in women with breast cancer: Population ‐based cohort study in New Zealand
ConclusionDisparities exist in the receipt of PMRT in breast cancer patients in New Zealand, underscoring the need for a greater equity focus in management of breast cancer. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - November 15, 2018 Category: Cancer & Oncology Authors: Phyu Mon Latt, Sandar Tin Tin, Mark Elwood, Ross Lawrenson, Ian Campbell Tags: ORIGINAL ARTICLE Source Type: research

Real ‐world efficacy and toxicity of combined nivolumab and ipilimumab in patients with metastatic melanoma
ConclusionIn this study, responses to combination immunotherapy were lower than reported. Patients treated with prior immunotherapy had similar responses as treatment ‐naïve pts. The toxicity profile seen in this study is similar to those reported in clinical trials. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - November 13, 2018 Category: Cancer & Oncology Authors: Sagun Parakh, Manreet Randhawa, Bella Nguyen, Lydia Warburton, Mohammad Akhtar Hussain, Jonathan Cebon, Michael Millward, Desmond Yip, Sayed Ali Tags: ORIGINAL ARTICLE Source Type: research

The potential “additive” thromboembolic risk of radiotherapy
Asia-Pacific Journal of Clinical Oncology, EarlyView. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - November 13, 2018 Category: Cancer & Oncology Authors: Marliese Alexander, Rebekka Sryjanen, David Ball, Michael MacManus, Kate Burbury Tags: LETTER TO THE EDITOR Source Type: research

Prognostic significance of BRAF mutation alone and in combination with microsatellite instability in stage III colon cancer
ConclusionBRAF ‐mutated cancers demonstrated a trend toward poorer outcomes, however, when adjusted for clinicopathological factors and chemotherapy, BRAF mutation was not found to be an independent prognostic biomarker in stage III colon cancer, even when combined with MSI. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - November 13, 2018 Category: Cancer & Oncology Authors: Hanumant Chouhan, Tarik Sammour, Michelle L. Thomas, James W. Moore Tags: ORIGINAL ARTICLE Source Type: research

Favorable 10 ‐year outcomes of image‐guided intensity‐modulated radiotherapy combined with long‐term androgen deprivation for Japanese patients with nonmetastatic prostate cancer
AbstractAimTo investigate 10 ‐year outcomes of high‐dose image‐guided intensity‐modulated radiation therapy (IG‐IMRT) combined with long‐term androgen deprivation therapy (ADT) for Japanese patients with nonmetastatic prostate cancer.MethodsA retrospective analysis was performed on 208 Japanese patients with T1 –4N0M0 prostate cancer, who underwent definitive IG‐IMRT from 2006 to 2010 at our single institution. The median dose was 78 Gy (74–78) and median ADT time was 32 months (6–151). The risk stratification followed the National Comprehensive Cancer Network criteria. A biochemical re...
Source: Asia-Pacific Journal of Clinical Oncology - November 8, 2018 Category: Cancer & Oncology Authors: Natsuo Tomita, Norihito Soga, Yuji Ogura, Jun Furusawa, Hiroshi Tanaka, Yutaro Koide, Hiroyuki Tachibana, Takeshi Kodira Tags: ORIGINAL ARTICLE Source Type: research

Association between PD ‐L1 expression and lymph node metastasis in cutaneous squamous cell carcinoma
ConclusionsThe results suggested that high intensity of PD ‐L1 expression in TCs is associated with lymph node metastasis in cSCC. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - November 8, 2018 Category: Cancer & Oncology Authors: Shiori Kamiya, Junji Kato, Takafumi Kamiya, Toshiharu Yamashita, Yasuyuki Sumikawa, Tokimasa Hida, Kohei Horimoto, Sayuri Sato, Hitomi Takahashi, Masahide Sawada, Terufumi Kubo, Toshihiko Torigoe, Hisashi Uhara Tags: ORIGINAL ARTICLE Source Type: research

Author index
Asia-Pacific Journal of Clinical Oncology,Volume 14, Issue S7, Page 203-212, November 2018. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - October 30, 2018 Category: Cancer & Oncology Source Type: research

Poster abstracts
Asia-Pacific Journal of Clinical Oncology,Volume 14, Issue S7, Page 91-202, November 2018. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - October 30, 2018 Category: Cancer & Oncology Source Type: research

Oral abstracts
Asia-Pacific Journal of Clinical Oncology,Volume 14, Issue S7, Page 50-90, November 2018. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - October 30, 2018 Category: Cancer & Oncology Source Type: research

Program in detail
Asia-Pacific Journal of Clinical Oncology,Volume 14, Issue S7, Page 25-49, November 2018. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - October 30, 2018 Category: Cancer & Oncology Source Type: research

National speakers
Asia-Pacific Journal of Clinical Oncology,Volume 14, Issue S7, Page 9-20, November 2018. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - October 30, 2018 Category: Cancer & Oncology Source Type: research

2018 cosa asm exhibitor profiles
Asia-Pacific Journal of Clinical Oncology,Volume 14, Issue S7, Page 215-218, November 2018. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - October 30, 2018 Category: Cancer & Oncology Source Type: research

Sponsors acknowledgements
Asia-Pacific Journal of Clinical Oncology,Volume 14, Issue S7, Page 24-24, November 2018. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - October 30, 2018 Category: Cancer & Oncology Source Type: research

International speakers
Asia-Pacific Journal of Clinical Oncology,Volume 14, Issue S7, Page 7-8, November 2018. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - October 30, 2018 Category: Cancer & Oncology Source Type: research

Highlighted lectures and awards 2018
Asia-Pacific Journal of Clinical Oncology,Volume 14, Issue S7, Page 5-6, November 2018. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - October 30, 2018 Category: Cancer & Oncology Source Type: research

Cosa committees
Asia-Pacific Journal of Clinical Oncology,Volume 14, Issue S7, Page 3-4, November 2018. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - October 30, 2018 Category: Cancer & Oncology Source Type: research

Convenor's welcome 2018
Asia-Pacific Journal of Clinical Oncology,Volume 14, Issue S7, Page 2-2, November 2018. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - October 30, 2018 Category: Cancer & Oncology Source Type: research

Exhibitor listing
Asia-Pacific Journal of Clinical Oncology,Volume 14, Issue S7, Page 214-214, November 2018. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - October 30, 2018 Category: Cancer & Oncology Source Type: research

Cosa president's welcome
Asia-Pacific Journal of Clinical Oncology,Volume 14, Issue S7, Page 1-1, November 2018. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - October 30, 2018 Category: Cancer & Oncology Source Type: research

Programat a glance
Asia-Pacific Journal of Clinical Oncology,Volume 14, Issue S7, Page 21-23, November 2018. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - October 30, 2018 Category: Cancer & Oncology Source Type: research

Floor plan
Asia-Pacific Journal of Clinical Oncology,Volume 14, Issue S7, Page 213-213, November 2018. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - October 30, 2018 Category: Cancer & Oncology Source Type: research

Satisfaction with pain management and impact of pain on quality of life in cancer patients
Asia-Pacific Journal of Clinical Oncology, EarlyView. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - October 18, 2018 Category: Cancer & Oncology Authors: Johnson Lin, Ruey ‐Kuen Hsieh, Jen‐Shi Chen, Kuan‐Der Lee, Kun‐Ming Rau, Yu‐Yun Shao, Yung‐Chuan Sung, Su‐Peng Yeh, Cheng‐Shyong Chang, Ta‐Chih Liu, Ming‐Fang Wu, Ming‐Yang Lee, Ming‐Sun Yu, Chia‐Jui Yen, Pang‐Yu Source Type: research

Clinicopathologic characteristics and outcome of patients with different EGFR mutations
Asia-Pacific Journal of Clinical Oncology, EarlyView. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - October 12, 2018 Category: Cancer & Oncology Authors: Shengyu Zhou, Xingsheng Hu, Yan Wang, Junling Li, Liqiang Zhou, Xuezhi Hao, Yutao Liu, Yuankai Shi Source Type: research

Gender ‐ and cholesterol‐specific predictive value of body mass index in renal cell carcinoma: A multicenter study
Asia-Pacific Journal of Clinical Oncology, EarlyView. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - October 11, 2018 Category: Cancer & Oncology Authors: Hyun Cheol Jeong, Fahad K. Bashraheel, Seok ‐Soo Byun, Cheol Kwak, Eu Chang Hwang, Seok Ho Kang, Jinsoo Chung, Tae‐Hwan Kim, Yong‐June Kim, Sung‐Hoo Hong Source Type: research

Issue Information
Asia-Pacific Journal of Clinical Oncology,Volume 14, Issue S6, Page 1-2, November 2018. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - October 9, 2018 Category: Cancer & Oncology Source Type: research

Author index
Asia-Pacific Journal of Clinical Oncology,Volume 14, Issue S6, Page 33-34, November 2018. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - October 9, 2018 Category: Cancer & Oncology Source Type: research

Poster abstracts
Asia-Pacific Journal of Clinical Oncology,Volume 14, Issue S6, Page 13-32, November 2018. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - October 9, 2018 Category: Cancer & Oncology Source Type: research

Invited speaker abstracts
Asia-Pacific Journal of Clinical Oncology,Volume 14, Issue S6, Page 9-12, November 2018. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - October 9, 2018 Category: Cancer & Oncology Source Type: research

Keynote speakers
Asia-Pacific Journal of Clinical Oncology,Volume 14, Issue S6, Page 7-8, November 2018. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - October 9, 2018 Category: Cancer & Oncology Source Type: research

2018 hunter cancer research symposium program
Asia-Pacific Journal of Clinical Oncology,Volume 14, Issue S6, Page 4-6, November 2018. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - October 9, 2018 Category: Cancer & Oncology Source Type: research

A message from the organizing committee
Asia-Pacific Journal of Clinical Oncology,Volume 14, Issue S6, Page 3-3, November 2018. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - October 9, 2018 Category: Cancer & Oncology Source Type: research

Current mismatch repair deficiency tumor testing practices and capabilities: A survey of Australian pathology providers
Asia-Pacific Journal of Clinical Oncology, EarlyView. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - October 8, 2018 Category: Cancer & Oncology Authors: Lyon Mascarenhas, Susan Shanley, Gillian Mitchell, Amanda B. Spurdle, Finlay Macrae, Nicholas Pachter, Daniel D. Buchanan, Robyn L. Ward, Stephen Fox, Elaine Duxbury, Rebecca Driessen, Alex Boussioutas Source Type: research

Issue Information
Asia-Pacific Journal of Clinical Oncology,Volume 14, Issue S4, Page 1-2, October 2018. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - October 5, 2018 Category: Cancer & Oncology Source Type: research

Emerging data and future directions for CDK4/6 inhibitor treatment of patients with hormone receptor positive HER2 ‐non‐amplified metastatic breast cancer
Asia-Pacific Journal of Clinical Oncology,Volume 14, Issue S4, Page 12-21, October 2018. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - October 5, 2018 Category: Cancer & Oncology Authors: Elgene Lim, Jane Beith, Frances Boyle, Richard Boer, Rina Hui, Nicole McCarthy, Andrew Redfern, Theresa Wade, Natasha Woodward Source Type: research

Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm
Asia-Pacific Journal of Clinical Oncology,Volume 14, Issue S4, Page 3-11, October 2018. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - October 5, 2018 Category: Cancer & Oncology Authors: Frances Boyle, Jane Beith, Katie Burslem, Richard Boer, Rina Hui, Elgene Lim, Nicole McCarthy, Andrew Redfern, Natasha Woodward Source Type: research

National and subnational mortality of urological cancers in Iran, 1990 –2015
Asia-Pacific Journal of Clinical Oncology, EarlyView. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - October 1, 2018 Category: Cancer & Oncology Authors: Farhad Pishgar, Erfan Amini, Kimiya Gohari, Arya Aminorroaya, Ali Sheidaei, Yasna Rostamabadi, Hooman Ebrahimi, Moein Yoosefi, Shohreh Naderimagham, Nazila Rezaei, Mitra Modirian, Alireza Namazi Shabestari, Farzad Kompani, Farshad Farzadfar Source Type: research

The prognostic significance of the expression of monocarboxylate transporter 4 in patients with right ‐ or left‐sided colorectal cancer
Asia-Pacific Journal of Clinical Oncology, EarlyView. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - October 1, 2018 Category: Cancer & Oncology Authors: Yukio Abe, Yoshifumi Nakayama, Takefumi Katsuki, Yuzuru Inoue, Noritaka Minagawa, Takayuki Torigoe, Aiichiro Higure, Tatsuhiko Sako, Naoki Nagata, Keiji Hirata Source Type: research

The impact and indications for Oncotype DX on adjuvant treatment recommendations when third ‐party funding is unavailable
Asia-Pacific Journal of Clinical Oncology, EarlyView. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - October 1, 2018 Category: Cancer & Oncology Authors: L. Chin ‐Lenn, R. H. Boer, E. Segelov, G. M. Marx, T. M. Hughes, N. J. McCarthy, S. C. White, S. S. Foo, J. J. Rutovitz, S. Della‐Fiorentina, R. Jennens, Y. C. Antill, D. Tsoi, M. F. Cronk, J. M. Lombard, B. E. Kiely, J. H. Chirgwin, Source Type: research

The outcomes of adrenalectomy for solitary adrenal metastasis: A 17 ‐year single‐center experience
Asia-Pacific Journal of Clinical Oncology, EarlyView. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - October 1, 2018 Category: Cancer & Oncology Authors: Koji Hatano, Sayaka Horii, Yasutomo Nakai, Masashi Nakayama, Ken ‐ichi Kakimoto, Kazuo Nishimura Source Type: research

Issue Information
Asia-Pacific Journal of Clinical Oncology,Volume 14, Issue 5, Page e211-e213, October 2018. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - September 18, 2018 Category: Cancer & Oncology Source Type: research

Is concomitant splenectomy necessary in radical gastric cancer surgery? A systematic review and meta ‐analysis
Asia-Pacific Journal of Clinical Oncology, EarlyView. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - September 4, 2018 Category: Cancer & Oncology Authors: QiuhongWang , TongDang , XianmeiMeng , KaiLi , WeiRen , XiujuanMa , YingHuang , XiaoboWu , WeijieHan , DongshengZhang , XiaolongLi , DaWang , LianshengZheng Source Type: research

Effect of C ‐reactive protein/albumin ratio on prognosis in advanced non–small‐cell lung cancer
Asia-Pacific Journal of Clinical Oncology, EarlyView. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - September 4, 2018 Category: Cancer & Oncology Authors: Xue ‐FengNi , JunWu , MeiJi , Ying‐JieShao , BinXu , Jing‐TingJiang , Chang‐PingWu Source Type: research

Issue Information
Asia-Pacific Journal of Clinical Oncology,Volume 14, Issue S3, Page 1-2, August 2018. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - July 18, 2018 Category: Cancer & Oncology Source Type: research

Author Index
Asia-Pacific Journal of Clinical Oncology,Volume 14, Issue S3, Page 76-78, August 2018. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - July 18, 2018 Category: Cancer & Oncology Source Type: research

Poster Abstracts
Asia-Pacific Journal of Clinical Oncology,Volume 14, Issue S3, Page 55-75, August 2018. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - July 18, 2018 Category: Cancer & Oncology Source Type: research

Plenary Session – Best of the Best Research 2018 Abstracts
Asia-Pacific Journal of Clinical Oncology,Volume 14, Issue S3, Page 50-54, August 2018. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - July 18, 2018 Category: Cancer & Oncology Source Type: research

Consultant Oral Session Abstracts
Asia-Pacific Journal of Clinical Oncology,Volume 14, Issue S3, Page 46-49, August 2018. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - July 18, 2018 Category: Cancer & Oncology Source Type: research

Trainee Oral Presentation Session Abstracts
Asia-Pacific Journal of Clinical Oncology,Volume 14, Issue S3, Page 42-45, August 2018. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - July 18, 2018 Category: Cancer & Oncology Source Type: research

Abstract Listing
Asia-Pacific Journal of Clinical Oncology,Volume 14, Issue S3, Page 37-41, August 2018. (Source: Asia-Pacific Journal of Clinical Oncology)
Source: Asia-Pacific Journal of Clinical Oncology - July 18, 2018 Category: Cancer & Oncology Source Type: research